Oncolytics Biotech Inc. (ONCY)

[onco_investor]

Oncolytics to Present at Wedbush 2011 Life Sciences Management Access Conference on August 16, 2011 at 8:35AM EDT

http://www.integratir.com/newsrelease.asp?news=2131025372&ticker=T.ONC&lang=EN&ny=on

CALGARY, AB, August 11, 2011 --- Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY), will present a corporate overview of the Company at the Wedbush 2011 Life Sciences Management Access Conference on Tuesday, August 16th, 2011 at 8:35 a.m. ET. The conference will take place from August 16th to 17th at the Le Parker Meridien Hotel in New York, NY.

A live audio link to the webcast presentation will be available at: http://wsw.com/webcast/wedbush17/oncy/ , or on the company’s website at www.oncolyticsbiotech.com. It is recommended that listeners log on 15 minutes in advance of the presentation to register and download any necessary software.

An audio replay will be accessible approximately one hour following the presentation on the Oncolytics website.

About Oncolytics Biotech Inc.
Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics’ clinical program includes a variety of human trials including a Phase III trial in head and neck cancers using REOLYSIN®, its proprietary formulation of the human reovirus. For further information about Oncolytics, please visit: www.oncolyticsbiotech.com.